Discrimination of human lung neoplasm from normal lung by two target genes

被引:41
作者
Hofmann, HS
Hansen, G
Burdach, S
Bartling, B
Silber, RE
Simm, A
机构
[1] Univ Halle Wittenberg, Dept Cardiothorac Surg, D-06097 Halle An Der Saale, Germany
[2] Univ Halle Wittenberg, Dept Pediat, D-06097 Halle An Der Saale, Germany
[3] Univ Halle Wittenberg, Childrens Canc Res Ctr, D-06097 Halle An Der Saale, Germany
[4] Tech Univ Munich, Dept Pediat, D-8000 Munich, Germany
关键词
cyclin-B2; lung cancer; lung metastases; receptor for advanced glycation end products; tissue discrimination;
D O I
10.1164/rccm.200407-127OC
中图分类号
R4 [临床医学];
学科分类号
1002 [临床医学]; 100602 [中西医结合临床];
摘要
Simple tools for discrimination of lung tissues can be useful in a fast machine-aided diagnosis, for example, bytumor-specific microarrays. We demonstrate that an easy ratio technique, based on the expression levels of only two genes differentially expressed in lung tumor and normal lung samples, allows discrimination of normal and neoplastic lung with a sensitivity of 100% and specificity of 90.5%. DNA microarray analysis of 99 lung tumor samples and 15 normal lung tissues revealed that receptor for advanced glycation end products (RAGE) mRNA is reduced fourfold (p = 7.8 x 10(-11)) and cyclin-B2 mRNA is upregulated twofold (p = 5.9 X 10(-18)) in lung carcinoma compared with normal lung. The microarray-calculated expression ratio of RAGE to cyclin-B2 was used in polymerase chain reaction analysis of 84 independent blinded samples to discriminate tumor and corresponding normal lung tissues. In 94.7% of the samples this quotient correctly distinguished non-small cell lung cancer from normal lung tissue, suggesting the RAGE/cyclin-B2 quotient as a potential means for diagnosis of lung cancer.
引用
收藏
页码:516 / 519
页数:4
相关论文
共 20 条
[1]
GenBank [J].
Benson, DA ;
Karsch-Mizrachi, I ;
Lipman, DJ ;
Ostell, J ;
Rapp, BA ;
Wheeler, DL .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :15-18
[2]
Identification and classification of differentially expressed genes in renal cell carcinoma by expression profiling on a global human 31,500-element cDNA array [J].
Boer, JM ;
Huber, WK ;
Sültmann, H ;
Wilmer, F ;
von Heydebreck, A ;
Haas, S ;
Korn, B ;
Gunawan, B ;
Vente, A ;
Füzesi, L ;
Vingron, M ;
Poustka, A .
GENOME RESEARCH, 2001, 11 (11) :1861-1870
[3]
A diagnostic test for prostate cancer from gene expression profiling data [J].
Bueno, R ;
Loughlin, KR ;
Powell, MH ;
Gordon, GJ .
JOURNAL OF UROLOGY, 2004, 171 (02) :903-906
[4]
Molecular classification of cancer: Class discovery and class prediction by gene expression monitoring [J].
Golub, TR ;
Slonim, DK ;
Tamayo, P ;
Huard, C ;
Gaasenbeek, M ;
Mesirov, JP ;
Coller, H ;
Loh, ML ;
Downing, JR ;
Caligiuri, MA ;
Bloomfield, CD ;
Lander, ES .
SCIENCE, 1999, 286 (5439) :531-537
[5]
Gordon GJ, 2002, CANCER RES, V62, P4963
[6]
Using gene expression ratios to predict outcome among patients with mesothelioma [J].
Gordon, GJ ;
Jensen, RV ;
Hsiao, LL ;
Gullans, SR ;
Blumenstock, JE ;
Richards, WG ;
Jaklitsch, MT ;
Sugarbaker, DJ ;
Bueno, R .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (08) :598-605
[7]
Cancer statistics, 2001 [J].
Greenlee, RT ;
Hill-Harmon, MB ;
Murray, T ;
Thun, M .
CA-A CANCER JOURNAL FOR CLINICIANS, 2001, 51 (01) :15-36
[8]
Huttunen HJ, 2002, CANCER RES, V62, P4805
[9]
Molecular profiling of human cancer [J].
Liotta, L ;
Petricoin, E .
NATURE REVIEWS GENETICS, 2000, 1 (01) :48-56
[10]
Lipsitt DR, 1999, GEN HOSP PSYCHIAT, V21, P1